drugset / Trial / NCT01309776

Comparison of Tianeptine Versus Escitalopram Patients Major Depressive Disorder

NCT01309776

Phase 4 Completed 164 enrolled Samsung Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

The primary object of this study is to confirm the superiority of tianeptine compared to escitalopram on effects that improves subjective and objective cognitive impairments in patients suffering from major depressive disorder.

Timeline

Start
2011-03
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Escitalopram Small molecule 10 mg
Subject Tianeptine Small molecule 37.5 mg